Back to company

Pharmaforce ApS: Financial statements 2019

CVR: 26394198

Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,813,985 and a net result of DKK 263,539 compared with DKK 1,177,199 the year before. That is a decrease of 23.6% compared with the year before. Equity amounted to DKK 1,427,084. The solvency ratio was 32.8%. The company had 4 employees in the financial year.

Gross Profit
2,813,985 kr.
Profit/Loss
263,539 kr.
Equity
1,427,084 kr.
Total Assets
4,357,012 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-2.8 mio.264 t.1.4 mio.4
2018-3.7 mio.1.2 mio.2.2 mio.3
2017-2.3 mio.826 t.986 t.2
2016-1.1 mio.-74 t.161 t.2
2015-312 t.149 t.234 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

Pharmaforce ApS: The 2018 annual report is outMay 7, 2019

Pharmaforce ApS has published its annual report for 2018. Gross profit came to DKK 3,684,787, and the net result was DKK 1,177,199.

About Pharmaforce ApS

Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity amounted to DKK 4,328,882.